NCT06627959

Brief Summary

This study, titled aims to compare two vascular closure techniques after catheter ablation for atrial fibrillation (AF). Catheter ablation is a common procedure used to treat AF, but after the procedure, It is important to close the access site in the blood vessel to prevent bleeding. This study will evaluate whether the StatSeal device, a haemostatic disc, can help patients recover more quickly compared to the traditional figure-of-eight suture technique. The primary objective of the study is to determine whether StatSeal reduces the time it takes for patients to start walking after the procedure (known as Time to Ambulation). Secondary objectives include comparing the time to complete haemostasis, discharge eligibility, incidence of adverse events, and patient comfort between the two techniques. Participants in the study will be randomly assigned to receive either the StatSeal device or the figure-of-eight suture after their AF ablation procedure. The study will recruit 160 participants across multiple hospital sites, with 80 participants in each group. Both techniques are standard methods, and participants will be closely monitored for safety throughout the study. By comparing these two closure techniques, the study aims to improve the recovery process for patients undergoing AF ablation and provide evidence on which method leads to better outcomes and patient experiences.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 4, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

January 3, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2025

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

December 23, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

October 1, 2024

Last Update Submit

December 22, 2025

Conditions

Keywords

atrial fibrillationvascular closureStatseal

Outcome Measures

Primary Outcomes (1)

  • Time to ambulation (TTA) after sheath removal

    Time to ambulation is defined as the elapsed time between removal of the final sheath and the moment when the patient can stand and walk 20 feet without evidence of venous re-bleeding from the femoral access site.

    1 day

Secondary Outcomes (7)

  • Time to haemostasis

    1 day

  • Time to discharge eligibility

    1 day

  • Time to discharge

    1 day

  • Incidence of major periprocedural adverse events

    1 day

  • Incidence of major adverse events

    30 days

  • +2 more secondary outcomes

Study Arms (2)

Statseal

ACTIVE COMPARATOR

This group shall receive the StatSeal device for vascular closure

Device: Statseal

Figure of eight suture

ACTIVE COMPARATOR

This group shall receive the figure of eight suture (attached to a three-way stopcock) for vascular closure

Device: Figure of eight suture

Interventions

StatsealDEVICE

This is a vascular closure device which works independently of the clotting cascade to seal access sites

Statseal

The figure of eight suture is commonly used for vascular access closure

Figure of eight suture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female patients age \>18
  • Elective catheter ablation for atrial fibrillation using a 6 to 14 Fr inner diameter introducer sheath with a minimum of 1 and maximum of 3 femoral venous access sites
  • Willing and able to give informed consent

You may not qualify if:

  • Active systemic or cutaneous infection, or inflammation in vicinity of the groin
  • Platelet count \< 100,000 cells/mm3
  • BMI \> 45 kg/m2 or \< 20 kg/m2
  • Attempted femoral arterial access or inadvertent arterial puncture
  • Procedural complications that interfered with routine recovery, ambulation, or discharge times
  • Incorrect sheath placement
  • Intraprocedural bleeding or thrombotic complications
  • Access site-specific eligibility criteria to exclude problems with gaining access or location of sheath
  • History of bleeding diathesis, coagulopathy, hypercoagulability, or thromboembolic events

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

The Essex Cardiothoracic Centre

Basildon, Essex, SS16 5NL, United Kingdom

Location

East Sussex Healthcare NHS Trust

Eastbourne, BN21 2UD, United Kingdom

Location

Norfolk and Norwich University Hospital

Norwich, NR4 7UY, United Kingdom

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2024

First Posted

October 4, 2024

Study Start

January 3, 2025

Primary Completion

December 12, 2025

Study Completion

January 1, 2026

Last Updated

December 23, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations